UQ3: S-{(3S,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5,10,14-tetraoxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} (2R)-2-hydroxypropanethioate
UQ3 is a Ligand Of Interest in 8VZA designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8VZA_UQ3_A_602 | 100% | 36% | 0.026 | 0.995 | 0.9 | 1.5 | 3 | 9 | 1 | 0 | 94% | 0.94 |
| 8VZA_UQ3_D_602 | 100% | 35% | 0.027 | 0.995 | 0.98 | 1.47 | 3 | 10 | 0 | 0 | 94% | 0.97 |
| 8VZA_UQ3_B_603 | 100% | 36% | 0.029 | 0.995 | 0.93 | 1.49 | 2 | 10 | 1 | 0 | 94% | 0.98 |
| 8VZA_UQ3_C_602 | 99% | 34% | 0.034 | 0.994 | 0.98 | 1.5 | 5 | 8 | 0 | 0 | 94% | 0.96 |
| 8VZB_UQ3_A_603 | 89% | 21% | 0.071 | 0.957 | 1.67 | 1.57 | 5 | 13 | 0 | 0 | 100% | 0.97 |
| 8E6O_UQ3_A_701 | 56% | 67% | 0.122 | 0.892 | 0.49 | 0.62 | 1 | 1 | 1 | 0 | 100% | 1 |
